Accentia Seeks Ch. 11 Shelter, Blames Credit Crunch
Citing a funding squeeze caused by the current global financial crisis, Accentia Biopharmaceuticals Inc. and several of its subsidiaries have filed petitions for Chapter 11 protection....To view the full article, register now.
Already a subscriber? Click here to view full article